Akebia Therapeutics Inc — 재무제표 (NASDAQ:AKBA) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 644.14 M525.55 M351.83 M241.7 M220.67 M376.56 M 총 부채 396.52 M449.09 M342.49 M272.29 M269.86 M343.95 M 자본금 총액 247.62 M76.46 M9.34 M-30.58 M-49.19 M32.61 M 총 부채 및 주주자본 644.14 M525.55 M351.83 M241.7 M220.67 M376.56 M 총부채 96.38 M034.08 M17.18 M38.69 M48.25 M 순부채 -172.31 M-149.8 M34.08 M17.18 M38.69 M-136.59 M

뉴스

Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates

United Therapeutics (UTHR) Misses Q1 Earnings and Revenue Estimates

Q32 Bio Gears Up to Report Q1 Earnings: What's in the Cards?

Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Tops Revenue Estimates

Are Options Traders Betting on a Big Move in Akebia Therapeutics Stock?

New Strong Sell Stocks for April 28th

Akebia Therapeutics, Inc. (AKBA) Discusses Pipeline Progress and Strategic Focus on Kidney Disease Treatments at R&D Day - Slideshow (NASDAQ:AKBA) 2026-04-04

Akebia Therapeutics, Inc. (AKBA) Discusses Pipeline Progress and Strategic Focus on Kidney Disease Treatments at R&D Day Transcript

Akebia Therapeutics, Inc. (AKBA) Presents at Leerink Global Healthcare Conference 2026 Transcript

아케비아, Leerink 컨퍼런스: Vafseo 및 파이프라인에 전략적 집중

Akebia at Leerink Conference: Strategic Focus on Vafseo and Pipeline

3 Best Stocks to Buy Today with 125%+ Upside, 2/27/2026, According to Top Analysts - TipRanks.com